MetLife Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$166K	Buy	50,024 +17,799	+55%	+$58.9K	﹤0.01%	2284
2025 Q1	$93.5K	Sell	32,225 -7,996	-20%	-$23.2K	﹤0.01%	2555
2024 Q4	$143K	Buy	40,221 +4,125	+11%	+$14.7K	﹤0.01%	2465
2024 Q3	$180K	Buy	36,096 +16,716	+86%	+$83.2K	﹤0.01%	2337
2024 Q2	$50.4K	Buy	+19,380	New	+$50.4K	﹤0.01%	2758